<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32159429</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>02</Day></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.</ArticleTitle><Pagination><StartPage>1586</StartPage><EndPage>1594</EndPage><MedlinePgn>1586-1594</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1709353</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) and Coxsackievirus A16 (CV-A16) are the two most common pathogens causing hand, foot, and mouth disease (HFMD). Previously, we obtained one candidate live attenuated strain each for EV-A71 and CV-A16; here, we evaluated the safety and immunogenicity of a combinedlive vaccine against EV-A71 and CV-A16 generated from these two candidate strains. Rhesus monkeys were intramuscularly treated with a live combinationvaccine against both EV-A71 and CV-A16 or with either vaccine alone. No fever or atypical clinical signs were observed in any animals. Monkeys vaccinated with the combinationlive vaccine presented no notable pathological changes in the brain, spinal cord, lung, and liver; in contrast, these regions showed inflammatory cell infiltration in monkeys treated with EV-A71 alone or CV-A16 alone. Weak viremia was detected in plasma after inoculation with the combinationvaccine; however, the duration of viral shedding in feces was increased. Biochemical studies revealed a slight increase in aspartate aminotransferase levels in monkeys inoculated with the live combination vaccine; however, histopathological findings did not attribute this change to liver damage. We also found that the live combinationvaccine induced a dual humoral immune response. Cytokine analysis indicated that the combined EV-A71/CV-A16 vaccine significantly down-regulated interleukin-8 production. Here, we have demonstrated that the live attenuated EV-A71/CV-A16 vaccine was safe and could trigger a dual specific immune response. However, its immune protection efficacy requires further investigation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Tianhong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Qinfang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Fanli</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Huaqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hospital Infection Control Department, The Affiliated Hospital of GuiZhou Medical University , Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Runxiang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Feiyu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Zhongping</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Institute of Medical Biology, Chinese Academic Medical Sciences &amp; Peking Union Medical College , Kunming, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017778">Vaccines, Combined</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017778" MajorTopicYN="N">Vaccines, Combined</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hand, foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">combination immunization</Keyword><Keyword MajorTopicYN="N">coxsackievirus 16</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32159429</ArticleId><ArticleId IdType="pmc">PMC7482759</ArticleId><ArticleId IdType="doi">10.1080/21645515.2019.1709353</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ.. Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial. Vaccine. 2012;30:3295&#x2013;303. doi:10.1016/j.vaccine.2012.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.03.010</ArticleId><ArticleId IdType="pubmed">22426327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024&#x2013;32. doi:10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829&#x2013;37. doi:10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Li H, Yue L, Song X, Xie T, Ma S, Meng H, Zhang Y, He X, Long R, et al. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro. Virol J. 2017;14:206. doi:10.1186/s12985-017-0872-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0872-8</ArticleId><ArticleId IdType="pmc">PMC5659012</ArticleId><ArticleId IdType="pubmed">29073897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y Study on the key technology of iyophilized experimental attenuated live attenuated vaccine of coxsackievirus A16[dissertation]. Chinese Academy of Medical Sciences &amp; Peking Union Medical College; 2018. doi:10.3168/jds.2017-14085</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2017-14085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SZ Attenuated characteristics and bioprocess assessment of CA16 vaccine candidates [dissertation]. Chinese Academy of Medical Sciences &amp; Peking Union Medical College; 2015.</Citation></Reference><Reference><Citation>Jiang GJ The selection of candidate strain of attenuated live coxsackievirus A16 vaccine [dissertation]. Chinese Academy of Medical Sciences &amp; Peking Union Medical College; 2014. doi:10.1094/PDIS-06-14-0565-PDN</Citation><ArticleIdList><ArticleId IdType="doi">10.1094/PDIS-06-14-0565-PDN</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F Development of EV71 live attenuated vaccines and the attenuation mechanism research [dissertation]. Chinese Academy of Medical Sciences &amp; Peking Union Medical College; 2016.</Citation></Reference><Reference><Citation>Zhang Y, Wang L, Liao Y, Liu L, Ma K, Yang E, Wang J, Che Y, Jiang L, Pu J, et al. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Vaccine. 2015;33:6290&#x2013;97. doi:10.1016/j.vaccine.2015.09.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.09.047</ArticleId><ArticleId IdType="pubmed">26419198</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo R, Cao YY, Dai ZZ, Qu SR, Zhuang JY. Characteristics of a human diploid cell line, KMB-17. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1981;3:226&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">6459859</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao JS, Dong DX, Zhang HY, Chen NL, Zhang XY, Huang HY, Xie RY, Zhou TJ, Wan ZJ, Wang YZ, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis. 1989;159:621&#x2013;24. doi:10.1093/infdis/159.4.621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/159.4.621</ArticleId><ArticleId IdType="pubmed">2538518</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Che Y, Yang B, Zhan F, Li H, Guan X, Zhang Y, Yin Q, Li C, Li J, et al. Immunogenicity and safety of an F-genotype attenuated mumps vaccine in healthy 8- to 24-month-old children. J Infect Dis. 2019;219:50&#x2013;58. doi:10.1093/infdis/jiy469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy469</ArticleId><ArticleId IdType="pubmed">30085178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang Y, Zhang X, Hu Y, Dong C, Liu L, Yang E, Che Y, Pu J, Wang X, et al. Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques. Virology. 2017;500:198&#x2013;208. doi:10.1016/j.virol.2016.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.10.031</ArticleId><ArticleId IdType="pubmed">27829175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FL, Li H, Xie TH, Yang T, Song X, Wang X, Shen D, Liu ZL, Yue L, Xie ZP. Dynamic changes of biological characteristics of EV-A71 strains continuously passaged in vitro at different temperatures. Chin J Viral Dis. 2016;6:113&#x2013;18.</Citation></Reference><Reference><Citation>Yang SZ, Xie TH, Li H, Jiang GJ, Long RX, Yang T, Yue L, Luo FY, Zhu FL, Xie ZP. Characteristics of live attenuated coxsackeivirus A16 candidate vaccine strain. Chin J Biol. 2015;28:441&#x2013;48.</Citation></Reference><Reference><Citation>Yang E, Cheng C, Zhang Y, Wang J, Che Y, Pu J, Dong C, Liu L, He Z, Lu S, et al. Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line. Hum Vaccin Immunother. 2014;10:1266&#x2013;73. doi:10.4161/hv.28083.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.28083</ArticleId><ArticleId IdType="pmc">PMC4896597</ArticleId><ArticleId IdType="pubmed">24583556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang GJ, Li H, Yang T, Liu ZL, Xie TH, Long RX, Yue L, Luo FY, Xie ZP. Biological characteristics of clinical isolates of coxsackievirus group A type 16. Chin J Biol. 2014;27:607&#x2013;11.</Citation></Reference><Reference><Citation>Dong C, Wang J, Liu L, Zhao H, Shi H, Zhang Y, Jiang L, Li Q. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys. Hum Vaccin. 2010;6:1028&#x2013;37. doi:10.4161/hv.6.12.12982.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.6.12.12982</ArticleId><ArticleId IdType="pubmed">21150270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhongping X, Hua L, Ting Y, Zhengling L, Min F, Tianhong X, Runxiang L, Dong S, Guangju J, Lei Y, et al. Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys. Virus Res. 2016;213:82&#x2013;89. doi:10.1016/j.virusres.2015.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.11.007</ArticleId><ArticleId IdType="pubmed">26555165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, Zhang Z, Zhang Y, Feng M, Fan S, Wang L, Liu L, Wang X, Wang Q, Zhang X, et al. Dynamic interaction of enterovirus 71 and dendritic cells in infected neonatal rhesus macaques. Front Cell Infect Microbiol. 2017;7:171. doi:10.3389/fcimb.2017.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00171</ArticleId><ArticleId IdType="pmc">PMC5423916</ArticleId><ArticleId IdType="pubmed">28540257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J Study of Coxsackievirus A16-infected rhesus monkeys macaques model and immunologic characteristics [dissertation]. Chinese Academy of Medical Sciences &amp; Peking Union Medical College, 2017.</Citation></Reference><Reference><Citation>Qi SD, Wang JJ, Zhang XL, Shen F, Li QH, Li YY, Liu LD, He ZL. Study on proliferation of coxsackievirus A16-infected peripheral blood mononuclear cells in rhesus monkeys. J Microbes Infections(Chinese). 2015;10:140&#x2013;46.</Citation></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798&#x2013;801. doi:10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother. 2012;8:668&#x2013;74. doi:10.4161/hv.19521.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.19521</ArticleId><ArticleId IdType="pubmed">22634437</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Wu JH, Zhu QJ. The statistical analysis of laboratory examination of hand, foot and mouth diseases in wuhan city in 2009. J Mathe Med. 2011;24:565&#x2013;67.</Citation></Reference><Reference><Citation>Gao LZ, Li SJ, Zuo J, Tang L. Study on changes of electrocardiogram and biochemical indexes of 128 children with EV71 severe hand-foot-and mouth-disease. China Med Pharm. 2017;7:69&#x2013;72.</Citation></Reference><Reference><Citation>HZ Y, Chu C, Ji W, XD L, XH Z, BQ L, Xu J, WF Z. Analysis of 139 cases of hand, foot and mouth disease. J Pract Med. 2011;27:4469&#x2013;70.</Citation></Reference><Reference><Citation>Li M, Duan Y, Yang X, Yang Q, Pang B, Wang Y, Ren T, Wang X, Zhao Z, Liu S. Intradermal injection of a fractional dose of an inactivated HFMD vaccine elicits similar protective immunity to intramuscular inoculation of a full dose of an Al(OH)3-adjuvanted vaccine. Vaccine. 2017;35:3709&#x2013;17. doi:10.1016/j.vaccine.2017.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.05.060</ArticleId><ArticleId IdType="pubmed">28576572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamik MK, Ghorpade A. CXCL8 as a potential therapeutic target for HIV-associated neurocognitive disorders. Curr Drug Targets. 2016;17:111&#x2013;21. doi:10.2174/1389450116666150626124544.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450116666150626124544</ArticleId><ArticleId IdType="pubmed">26112047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564&#x2013;70. doi:10.1086/376998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye N, Gong X, Pang LL, Gao WJ, Zhang YT, Li XL, Liu N, Li DD, Jin Y, Duan ZJ. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225. doi:10.1186/s12879-015-0965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0965-1</ArticleId><ArticleId IdType="pmc">PMC4461975</ArticleId><ArticleId IdType="pubmed">26058678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ. 2004;82:16&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2585883</ArticleId><ArticleId IdType="pubmed">15106296</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CCY, Lau SKP, Woo PCY, Yuen K-Y. Human enterovirus 71 epidemics: what&#x2019;s next? Emerg Health Threats J. 2013;6:19780&#x2013;19780. doi:10.3402/ehtj.v6i0.19780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/ehtj.v6i0.19780</ArticleId><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandary MB, Poh CL. Changes in the EV-A71 genome through recombination and spontaneous mutations: impact on virulence. Viruses. 2018;10:320. doi:10.3390/v10060320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10060320</ArticleId><ArticleId IdType="pmc">PMC6024729</ArticleId><ArticleId IdType="pubmed">29895721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>